Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci
- 1 July 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (7) , 1570-1572
- https://doi.org/10.1128/aac.36.7.1570
Abstract
The in vitro activities of teicoplanin, daptomycin, ramoplanin, and PD127,391, a new quinolone, were compared with that of vancomycin. Teicoplanin showed the lowest MICs against Enterococcus faecalis. Ramoplanin was slightly more active than the other peptide antibiotics against oxacillin-resistant Staphylococcus aureus. The MICs of the four peptide antibiotics were similar for the oxacillin-susceptible S. aureus. Daptomycin had good activity against staphylococci but was the least active agent against E. faecalis. The MICs of vancomycin against all isolates were in general higher than those of the new antibiotics, with the exceptions of the MICs of daptomycin against E. faecalis and teicoplanin against oxacillin-resistant Staphylococcus epidermidis. PD127,391 was the most active agent against all staphylococcal isolates.Keywords
This publication has 21 references indexed in Scilit:
- In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficileJournal of Antimicrobial Chemotherapy, 1990
- Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelAntimicrobial Agents and Chemotherapy, 1990
- Suboptimal Effect of Daptomycin in the Treatment of BacteremiasSouthern Medical Journal, 1989
- Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1989
- Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivativeAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of PD 127,391, an enhanced-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1988
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- VANCOMYCIN-RESISTANT ENTEROCOCCIThe Lancet, 1988
- In-vitro susceptibility of Gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicinJournal of Antimicrobial Chemotherapy, 1987
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987